Cargando…

Application of an Artificial Neural Network in the Diagnosis of Chronic Lymphocytic Leukemia

Introduction Chronic lymphocytic leukemia (CLL) is one of the most common types of leukemia, and the early diagnosis of patients coincides with their proper treatment and survival. If patients are diagnosed late or proper treatment is not applied, it may lead to harmful results. Several methods coul...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaabanpour Aghamaleki, Fateme, Mollashahi, Behrouz, Nosrati, Mokhtar, Moradi, Afshin, Sheikhpour, Mojgan, Movafagh, Abolfazl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450593/
https://www.ncbi.nlm.nih.gov/pubmed/31001458
http://dx.doi.org/10.7759/cureus.4004
_version_ 1783409046569615360
author Shaabanpour Aghamaleki, Fateme
Mollashahi, Behrouz
Nosrati, Mokhtar
Moradi, Afshin
Sheikhpour, Mojgan
Movafagh, Abolfazl
author_facet Shaabanpour Aghamaleki, Fateme
Mollashahi, Behrouz
Nosrati, Mokhtar
Moradi, Afshin
Sheikhpour, Mojgan
Movafagh, Abolfazl
author_sort Shaabanpour Aghamaleki, Fateme
collection PubMed
description Introduction Chronic lymphocytic leukemia (CLL) is one of the most common types of leukemia, and the early diagnosis of patients coincides with their proper treatment and survival. If patients are diagnosed late or proper treatment is not applied, it may lead to harmful results. Several methods could be used for the diagnosis of leukemia; some of these include complete blood count (CBC), immunophenotyping, lymph node biopsy, chest X-ray, computerized tomography (CT) scan, and ultrasound. Most of these methods are time-consuming and an application of more than one method will result as intended. This acknowledgment stresses the necessity of rapid and proper diagnosis for leukemia based on clinical and medical findings, inasmuch as it was decided to apply the artificial neural network (ANN) in order to identify a molecular biomarker for rapid leukemia diagnosis from blood samples and evaluate its potential for the detection of cancer. Materials & methods The independent sample t-test was applied with the Statistical Package for the Social Sciences (SPSS; IBM Corp, Armonk, NY, US) software on the microarray gene expression data of Gene Expression Omnibus (GEO) datasets (GSE22529); 12 genes that had shown the highest differences (among parameters whose p-value was less than 0.01) were selected for further ANN analysis. The selected genes of 53 patients were applied to the training network algorithm, with a learning rate of 0.1. Results The results showed a high accuracy of the relationship between the output of the trained network and the test data. The area under the receiver operating characteristic (ROC) curve was 0.991, which provides proof of the precision and the relationship with identifying Gelsolin as a potential biomarker for this research. Conclusions With these results, it was concluded that the training process of the ANN could be applied to rapid CLL diagnosis and finding a potential biomarker. Besides, it is suggested that this method could be performed to diagnose other forms of cancer in order to get a rapid and reliable outcome.
format Online
Article
Text
id pubmed-6450593
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-64505932019-04-18 Application of an Artificial Neural Network in the Diagnosis of Chronic Lymphocytic Leukemia Shaabanpour Aghamaleki, Fateme Mollashahi, Behrouz Nosrati, Mokhtar Moradi, Afshin Sheikhpour, Mojgan Movafagh, Abolfazl Cureus Genetics Introduction Chronic lymphocytic leukemia (CLL) is one of the most common types of leukemia, and the early diagnosis of patients coincides with their proper treatment and survival. If patients are diagnosed late or proper treatment is not applied, it may lead to harmful results. Several methods could be used for the diagnosis of leukemia; some of these include complete blood count (CBC), immunophenotyping, lymph node biopsy, chest X-ray, computerized tomography (CT) scan, and ultrasound. Most of these methods are time-consuming and an application of more than one method will result as intended. This acknowledgment stresses the necessity of rapid and proper diagnosis for leukemia based on clinical and medical findings, inasmuch as it was decided to apply the artificial neural network (ANN) in order to identify a molecular biomarker for rapid leukemia diagnosis from blood samples and evaluate its potential for the detection of cancer. Materials & methods The independent sample t-test was applied with the Statistical Package for the Social Sciences (SPSS; IBM Corp, Armonk, NY, US) software on the microarray gene expression data of Gene Expression Omnibus (GEO) datasets (GSE22529); 12 genes that had shown the highest differences (among parameters whose p-value was less than 0.01) were selected for further ANN analysis. The selected genes of 53 patients were applied to the training network algorithm, with a learning rate of 0.1. Results The results showed a high accuracy of the relationship between the output of the trained network and the test data. The area under the receiver operating characteristic (ROC) curve was 0.991, which provides proof of the precision and the relationship with identifying Gelsolin as a potential biomarker for this research. Conclusions With these results, it was concluded that the training process of the ANN could be applied to rapid CLL diagnosis and finding a potential biomarker. Besides, it is suggested that this method could be performed to diagnose other forms of cancer in order to get a rapid and reliable outcome. Cureus 2019-02-04 /pmc/articles/PMC6450593/ /pubmed/31001458 http://dx.doi.org/10.7759/cureus.4004 Text en Copyright © 2019, Shaabanpour Aghamaleki et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Genetics
Shaabanpour Aghamaleki, Fateme
Mollashahi, Behrouz
Nosrati, Mokhtar
Moradi, Afshin
Sheikhpour, Mojgan
Movafagh, Abolfazl
Application of an Artificial Neural Network in the Diagnosis of Chronic Lymphocytic Leukemia
title Application of an Artificial Neural Network in the Diagnosis of Chronic Lymphocytic Leukemia
title_full Application of an Artificial Neural Network in the Diagnosis of Chronic Lymphocytic Leukemia
title_fullStr Application of an Artificial Neural Network in the Diagnosis of Chronic Lymphocytic Leukemia
title_full_unstemmed Application of an Artificial Neural Network in the Diagnosis of Chronic Lymphocytic Leukemia
title_short Application of an Artificial Neural Network in the Diagnosis of Chronic Lymphocytic Leukemia
title_sort application of an artificial neural network in the diagnosis of chronic lymphocytic leukemia
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450593/
https://www.ncbi.nlm.nih.gov/pubmed/31001458
http://dx.doi.org/10.7759/cureus.4004
work_keys_str_mv AT shaabanpouraghamalekifateme applicationofanartificialneuralnetworkinthediagnosisofchroniclymphocyticleukemia
AT mollashahibehrouz applicationofanartificialneuralnetworkinthediagnosisofchroniclymphocyticleukemia
AT nosratimokhtar applicationofanartificialneuralnetworkinthediagnosisofchroniclymphocyticleukemia
AT moradiafshin applicationofanartificialneuralnetworkinthediagnosisofchroniclymphocyticleukemia
AT sheikhpourmojgan applicationofanartificialneuralnetworkinthediagnosisofchroniclymphocyticleukemia
AT movafaghabolfazl applicationofanartificialneuralnetworkinthediagnosisofchroniclymphocyticleukemia